Induction of cytotoxic T lymphocytes by CEA peptide-pulsed γδ T-cells isolated from patients with advanced cancer

Akio Yamasaki, Hideya Ohnishi, Takashi Morisaki, Mitsuo Katano

研究成果: ジャーナルへの寄稿記事

6 引用 (Scopus)

抄録

Cytotoxic γδ T-cells recognize antigens directly without the need for antigen processing and presentation. Recently, it was reported that they can also present antigens and proliferate in vitro. In this study, we examined whether γδ T-cells isolated from patients with advanced cancer can be used for immunotherapy. Twenty-two inoperable patients with multiple cancer metastases were enrolled in the study. There was no significant difference in the ratio of γδ T-cells within the peripheral blood mononuclear cell population isolated from healthy volunteers and cancer patients. γδ T-Cells isolated from cancer patients were expanded 2- to 5-fold using zoledronic acid or 2-methyl-3butenyl-1-pyrophosphate and IL-2. Autologous CD8+ T-cells cocultured with expanded CEA peptide-pulsed γδ T-cells from cancer patients with HLA-A24 killed more CEA-positive HLA-A24-matched gastric cancer cells and secreted higher levels of interferon-γ. These results suggest that γδ T-cells from cancer patients may be ideal candidates for adoptive immunotherapy.

元の言語英語
ページ(範囲)2419-2424
ページ数6
ジャーナルAnticancer Research
31
発行部数7
出版物ステータス出版済み - 7 2011

Fingerprint

Peptide T
Cytotoxic T-Lymphocytes
T-Lymphocytes
HLA-A24 Antigen
Neoplasms
zoledronic acid
Antigen Presentation
Adoptive Immunotherapy
Antigens
Immunotherapy
Interferons
Stomach Neoplasms
Interleukin-2
Blood Cells
Healthy Volunteers
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

これを引用

Induction of cytotoxic T lymphocytes by CEA peptide-pulsed γδ T-cells isolated from patients with advanced cancer. / Yamasaki, Akio; Ohnishi, Hideya; Morisaki, Takashi; Katano, Mitsuo.

:: Anticancer Research, 巻 31, 番号 7, 07.2011, p. 2419-2424.

研究成果: ジャーナルへの寄稿記事

Yamasaki, Akio ; Ohnishi, Hideya ; Morisaki, Takashi ; Katano, Mitsuo. / Induction of cytotoxic T lymphocytes by CEA peptide-pulsed γδ T-cells isolated from patients with advanced cancer. :: Anticancer Research. 2011 ; 巻 31, 番号 7. pp. 2419-2424.
@article{3383b94d1ed143d38c197472745ce8bb,
title = "Induction of cytotoxic T lymphocytes by CEA peptide-pulsed γδ T-cells isolated from patients with advanced cancer",
abstract = "Cytotoxic γδ T-cells recognize antigens directly without the need for antigen processing and presentation. Recently, it was reported that they can also present antigens and proliferate in vitro. In this study, we examined whether γδ T-cells isolated from patients with advanced cancer can be used for immunotherapy. Twenty-two inoperable patients with multiple cancer metastases were enrolled in the study. There was no significant difference in the ratio of γδ T-cells within the peripheral blood mononuclear cell population isolated from healthy volunteers and cancer patients. γδ T-Cells isolated from cancer patients were expanded 2- to 5-fold using zoledronic acid or 2-methyl-3butenyl-1-pyrophosphate and IL-2. Autologous CD8+ T-cells cocultured with expanded CEA peptide-pulsed γδ T-cells from cancer patients with HLA-A24 killed more CEA-positive HLA-A24-matched gastric cancer cells and secreted higher levels of interferon-γ. These results suggest that γδ T-cells from cancer patients may be ideal candidates for adoptive immunotherapy.",
author = "Akio Yamasaki and Hideya Ohnishi and Takashi Morisaki and Mitsuo Katano",
year = "2011",
month = "7",
language = "English",
volume = "31",
pages = "2419--2424",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "7",

}

TY - JOUR

T1 - Induction of cytotoxic T lymphocytes by CEA peptide-pulsed γδ T-cells isolated from patients with advanced cancer

AU - Yamasaki, Akio

AU - Ohnishi, Hideya

AU - Morisaki, Takashi

AU - Katano, Mitsuo

PY - 2011/7

Y1 - 2011/7

N2 - Cytotoxic γδ T-cells recognize antigens directly without the need for antigen processing and presentation. Recently, it was reported that they can also present antigens and proliferate in vitro. In this study, we examined whether γδ T-cells isolated from patients with advanced cancer can be used for immunotherapy. Twenty-two inoperable patients with multiple cancer metastases were enrolled in the study. There was no significant difference in the ratio of γδ T-cells within the peripheral blood mononuclear cell population isolated from healthy volunteers and cancer patients. γδ T-Cells isolated from cancer patients were expanded 2- to 5-fold using zoledronic acid or 2-methyl-3butenyl-1-pyrophosphate and IL-2. Autologous CD8+ T-cells cocultured with expanded CEA peptide-pulsed γδ T-cells from cancer patients with HLA-A24 killed more CEA-positive HLA-A24-matched gastric cancer cells and secreted higher levels of interferon-γ. These results suggest that γδ T-cells from cancer patients may be ideal candidates for adoptive immunotherapy.

AB - Cytotoxic γδ T-cells recognize antigens directly without the need for antigen processing and presentation. Recently, it was reported that they can also present antigens and proliferate in vitro. In this study, we examined whether γδ T-cells isolated from patients with advanced cancer can be used for immunotherapy. Twenty-two inoperable patients with multiple cancer metastases were enrolled in the study. There was no significant difference in the ratio of γδ T-cells within the peripheral blood mononuclear cell population isolated from healthy volunteers and cancer patients. γδ T-Cells isolated from cancer patients were expanded 2- to 5-fold using zoledronic acid or 2-methyl-3butenyl-1-pyrophosphate and IL-2. Autologous CD8+ T-cells cocultured with expanded CEA peptide-pulsed γδ T-cells from cancer patients with HLA-A24 killed more CEA-positive HLA-A24-matched gastric cancer cells and secreted higher levels of interferon-γ. These results suggest that γδ T-cells from cancer patients may be ideal candidates for adoptive immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=79961200577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961200577&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 2419

EP - 2424

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 7

ER -